State Street SPDR S&P Pharmaceuticals (XPH) ETF Holdings & Analysis

What XPH does

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

Fund profile

Top holdings

Sector allocation

Geographic allocation

PortView Portfolio Insights

PortView analyzes how XPH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Related securities

Related stocks

Frequently asked questions

What does XPH track?

XPH is the State Street SPDR S&P Pharmaceuticals ETF, a Other ETF.

What is the expense ratio of XPH?

Expense ratio data for XPH is shown on the page when available from our data provider.

What are the largest holdings in XPH?

Top holdings include AMLX, MBX, ATAI, OMER, DFTX.

How can PortView analyze XPH overlap with other ETFs?

PortView computes the holdings overlap between XPH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.